___

• 1. Thienpont LM, Uytfanghe KV, Poppe K, Velkeniers B. Determination of free thyroid hormones. Best Pract Res Clin Endocrinol Metab. 2013; 27: 689-700.
• 2. Carvalho GAD, Perez CLS, Ward LS. The clinical use of thyroid function tests. Arquivos Brasileiros de Endocrinologia & Metabologia. 2013; 57(3): 193-204.
• 3. Sheenan MT. Biochemical testing of the thyroid: TSH is the best and, oftentimes, only test needed–a review for primary care. Clinical medicine & research, 2016, 14.2: 83-92.
• 4. Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. The Lancet Diabetes & Endocrinology. 2015; 3(10): 816-825.
• 5. Warner MH, Beckett GJ. Mechanisms behind the non-thyroidal illness syndrome: an update. Journal of Endocrinology 2010;205: 1-13.
• 6. Gaitonde DY, Rowley KD, Sweeney LB. "Hypothyroidism: an update." South African Family Practice 54.5 (2012): 384-390.
• 7. Spencer CA. Clinical utility and cost-effectiveness of sensitive thyro¬tropin assays in ambulatory and hospitalized patients. Mayo Clin Proc. 1988;63 (12): 1214-1222.
• 8. http://temd.org.tr/Kilavuzlar (Erişim tarihi: 19.03.2019)
• 9. Garber JR, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid, 2012, 22.12: 1200-1235.
• 10. Diez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004;89: 4890-4987.
• 11. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twentyyear follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43: 55-68.
• 12. Marinò M, Latrofa F, Menconi F, Chiovato L, Vitti P. Role of genetic and non-genetic factors in the etiology of Graves’ disease. J Endocrinol Invest. 2015;38: 283–94.
• 13. Devereaux D, Tewelde SZ. Hyperthyroidism and thyrotoxicosis. Emerg Med Clin North Am. 2014; 32: 277–92.
• 14. Bartalena L, Fatourechi V. Extrathyroidal manifestations of Graves’ disease: a 2014 update. J Endocrinol Invest. 2014;37: 691–700.
• 15. Vaidya B, Pearce SH. Diagnosis and management of thyrotoxicosis. BMJ. 2014; 349:g5128.
• 16. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet 2016; 388: 906-918.
• 17. Canaris GJ, et al. The Colorado thyroid disease prevalence study. Archives of internal medicine, 2000, 160.4: 526-534.
• 18. Rosario PW. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0• 1 and 0• 4 mIU/l: a prospective study. Clinical endocrinology, 2010, 72.5: 685-688.
• 19. Rosario PW. The natural history of subclinical hyperthyroidism in patients below the age of 65 years. Clinical endocrinology, 2008, 68.3: 491-492.
• 20. Blum MR, et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. Jama, 2015, 313.20: 2055-2065.
• 21. Ross DS, et al. American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid, 2016, 26.10: 1343-1421.
• 22. DeGroot L, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 2012, 97.8: 2543-2565.
• 23. Yassa L, et al. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. The Journal of Clinical Endocrinology & Metabolism, 2010, 95.7: 3234-3241.
• 24. Stagnaro-Green A, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid, 2011, 21.10: 1081-1125.
• 25. Aile Hekimliği Uygulamasında Önerilen Periyodik Sağlık Muayeneleri ve Tarama Testleri. T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu, yayın no: 991, 2015.
• 26. LeFevre ML. Screening for thyroid dysfunction: US Preventive Services Task Force recommendation statement. Annals of internal medicine, 2015, 162.9: 641-650.